Developer docs
API playgroundTry for free, no card

Search company profiles

Poly Pharmaceuticals

Full company profile

uuid000qkzc

Namestring
Poly Pharmaceuticals
Legal namestring
Poly Pharmaceuticals, Inc.
Websiteurl
polypharm.net
Company typeenum
Private
Founded yearint
1980
Descriptiontext

Poly Pharmaceuticals, Inc. is a privately held specialty pharmaceutical company founded in 1980 in Owens Cross Roads, Alabama, by a group of pharmacists. The company develops, manufactures, markets, and distributes branded, generic, and over-the-counter therapeutic products focused on four therapeutic areas: cough and cold, pain management, urological health, and allergy and sinusitis. Its portfolio consists of seven core product lines — Alahist, Deconex, Duraflu, Poly Hist, Poly Tussin, Poly Vent, and Udamin SP — available in tablet and liquid formulations, alongside co-promoted products including Kristalose 10mg and 20mg.

The company generates revenue through the manufacture and sale of these pharmaceutical products distributed to physicians, pharmacies, and wholesale distributors throughout the United States. Its go-to-market motion is sales-led, relying on a dedicated sales force that engages healthcare practitioners directly; the corporate website supplements this with sample-request functionality gated behind DEA and NPI credentials. Products reach patients via retail pharmacy channels and wholesale distribution networks across domestic markets. Pricing is not publicly disclosed.

Poly operates with a small team (reported 1–10 employees) and pursues portfolio expansion primarily through strategic business alliances, in-licensing arrangements, and targeted acquisitions rather than large-scale internal R&D. The company is registered as a corporation in Alabama, has an active website and careers channel, and continues to launch new products annually under its existing brand portfolio and via co-promotion agreements. <parameter name="company_description_short">

Short descriptiontext

Poly Pharmaceuticals is a privately held, Alabama-based specialty pharmaceutical company founded in 1980 that manufactures and distributes branded, generic, and OTC therapeutics for cough/cold, allergy, pain, and urological health to physicians, pharmacies, and wholesalers across the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersQuitman, United States
HQ citystring
Quitman
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmaceuticals, cough cold medications, generic drug manufacturing, OTC pharmaceuticals, prescription therapeutics
Industry2 codes
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAM
Nephrology & Urology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Specialty Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Revenue generated through the manufacture, marketing, and distribution of branded, generic, and OTC pharmaceutical products to healthcare providers, pharmacies, and wholesalers.

polypharm.net
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Alahist
Description

Product line including Alahist CF, Alahist IR, Alahist PE, Alahist DM

polypharm.net
+6 more records
Core offering1 text field

Poly Pharmaceuticals is an independent specialty pharmaceutical company that manufactures, markets, and distributes branded, generic, and OTC therapeutic products in tablet and liquid formulations. Its portfolio targets four therapeutic areas — cough and cold, pain management, urological health, and allergy/sinusitis — and is organized into seven core product lines (Alahist, Deconex, Duraflu, Poly Hist, Poly Tussin, Poly Vent, Udamin SP) plus co-promoted Kristalose products. Products are sold to physicians, pharmacies, and wholesalers throughout the United States.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Poly Pharmaceuticals is an independent specialty pharmaceutical company that manufactures, markets, and distributes branded, generic, and OTC therapeutic products. The company operates as a single product portfolio rather than a unified platform architecture, organized into multiple product lines targeting cough and cold, pain management, urological health, and allergy and sinusitis conditions. Their product portfolio includes seven core product lines—Alahist, Deconex, Duraflu, Poly Hist, Poly Tussin, Poly Vent, and Udamin SP—along with co-promoted products (Kristalose 10mg and 20mg). Products are distributed in tablet and liquid formulations to physicians, pharmacies, and wholesalers throughout the United States.

Product and service8 records
1Alahist
CategoryCough and cold medications
Description

Product line of cough and cold medications available in tablet form (Alahist CF, Alahist IR, Alahist PE) and liquid form (Alahist DM), distributed to physicians, pharmacies, and wholesalers across the United States.

2Deconex
CategoryDecongestant medications
Description

Product line of decongestant medications available in tablet form (Deconex IR, Deconex DMX), distributed to physicians, pharmacies, and wholesalers in the United States.

3Duraflu
CategoryCold medications
Description

Tablet-form cold medication product line distributed to physicians, pharmacies, and wholesalers in the United States.

4Poly Hist
CategoryAntihistamine and cold medications
Description

Product line of antihistamine/cold medications available in multiple formulations (Poly-Hist Forte, Poly-Hist DM, Poly-Hist PD), distributed to physicians, pharmacies, and wholesalers in the United States.

5Poly Tussin
CategoryCough suppressants
Description

Liquid cough suppressant product line (Polytussin DM) distributed to physicians, pharmacies, and wholesalers in the United States.

6Poly Vent
CategoryRespiratory and cold medications
Description

Product line of respiratory/cold medications available in tablet form (Poly Vent IR, Poly Vent DM), distributed to physicians, pharmacies, and wholesalers in the United States.

7Udamin SP
CategoryUrological health
Description

Urological health product line distributed to physicians, pharmacies, and wholesalers in the United States.

8Kristalose
CategoryCo-promoted prescription laxative
Description

Co-promoted prescription laxative product available in 10mg and 20mg dosages, distributed to physicians, pharmacies, and wholesalers in the United States.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Poly Pharmaceuticals brings new products to market each year through strategic business alliances, acquisitions, product development, and licensing arrangements. These partnerships support the company's product portfolio expansion in therapeutic areas including cough/cold, pain management, urological health, and allergy/sinusitis.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Larger specialty/generic pharma with U.S. manufacturing and broad therapeutic reach including urology — broader portfolio but overlapping channels and customer base with Poly.

TypeBroad incumbent
Description

Diversified U.S. generic and specialty pharma distributing through wholesalers and pharmacies — same B2B distribution channels and customer types as Poly, though at significantly larger scale.

TypeBroad incumbent
Description

Major consumer-health/OTC company with leading brands across cough/cold, allergy, and pain — competes head-on with Poly's core OTC categories despite vastly different scale.

TypeDirect peer
Description

Specialty pharmaceutical company focused on branded prescription products in CNS, women's health, and urology — comparable scale, sales-led distribution model, and therapeutic categories.

TypeDirect peer
Description

Specialty pharma commercializing prescription and consumer health products with a dedicated sales force in urology, pediatrics, and primary care — similar channel structure and therapeutic-area strategy to Poly.

6Padagis
TypeBroad incumbent
Description

Specialty generics and OTC pharmaceutical company with strong cough/cold and respiratory franchises (e.g., historically a major player in cough/cold remedies) — directly competes in Poly's core therapeutic categories and share the same pharmacy/wholesaler channels.

7Avion Pharmaceuticals
TypeDirect peer
Description

Independent U.S. specialty pharma focused on women's health, urology, and primary care, distributing through physicians, pharmacies, and wholesalers — directly comparable business model and therapeutic overlap with Poly (notably urology).

TypeBroad incumbent
Description

Global consumer-health company owning major OTC brands in cough/cold, allergy, and pain management — competes aggressively in the same shelf categories where Poly's products are dispensed.

9Founded Pharmaceuticals (Innocutis/Foundrax)
TypeEmerging player
Description

Smaller specialty pharma distributing niche branded and prescription products via physician/pharmacy channels with similar lean operating profile to Poly.

TypeDirect peer
Description

Small U.S. specialty pharmaceutical company marketing branded prescription and OTC products through physician and pharmacy channels — closely mirrors Poly's specialty distribution model and therapeutic-area breadth.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Poly Pharmaceuticals

Specialty Pharmaceuticalspolypharm.net

Poly Pharmaceuticals is a privately held, Alabama-based specialty pharmaceutical company founded in 1980 that manufactures and distributes branded, generic, and OTC therapeutics for cough/cold, allergy, pain, and urological health to physicians, pharmacies, and wholesalers across the United States.

What Poly Pharmaceuticals does

Poly Pharmaceuticals, Inc. is a privately held specialty pharmaceutical company founded in 1980 in Owens Cross Roads, Alabama, by a group of pharmacists. The company develops, manufactures, markets, and distributes branded, generic, and over-the-counter therapeutic products focused on four therapeutic areas: cough and cold, pain management, urological health, and allergy and sinusitis. Its portfolio consists of seven core product lines — Alahist, Deconex, Duraflu, Poly Hist, Poly Tussin, Poly Vent, and Udamin SP — available in tablet and liquid formulations, alongside co-promoted products including Kristalose 10mg and 20mg.

The company generates revenue through the manufacture and sale of these pharmaceutical products distributed to physicians, pharmacies, and wholesale distributors throughout the United States. Its go-to-market motion is sales-led, relying on a dedicated sales force that engages healthcare practitioners directly; the corporate website supplements this with sample-request functionality gated behind DEA and NPI credentials. Products reach patients via retail pharmacy channels and wholesale distribution networks across domestic markets. Pricing is not publicly disclosed.

Poly operates with a small team (reported 1–10 employees) and pursues portfolio expansion primarily through strategic business alliances, in-licensing arrangements, and targeted acquisitions rather than large-scale internal R&D. The company is registered as a corporation in Alabama, has an active website and careers channel, and continues to launch new products annually under its existing brand portfolio and via co-promotion agreements. <parameter name="company_description_short">

Poly Pharmaceuticals firmographics

Firmographics
Name
Poly Pharmaceuticals
Legal name
Poly Pharmaceuticals, Inc.
Website
https://polypharm.net
Company type
Private
Founded year
1980
Operating status
Operating
Headcount range
11–50 employees
Short description
Poly Pharmaceuticals is a privately held, Alabama-based specialty pharmaceutical company founded in 1980 that manufactures and distributes branded, generic, and OTC therapeutics for cough/cold, allergy, pain, and urological health to physicians, pharmacies, and wholesalers across the United States.
Ownership category
akta.pro rank

Poly Pharmaceuticals industry classification

Industry
Product category
Specialty Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAM
Nephrology & Urology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Specialty pharmaceuticals
  • Cough cold medications
  • Generic drug manufacturing
  • OTC pharmaceuticals
  • Prescription therapeutics

Where Poly Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Quitman
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Poly Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmaceutical Product Sales: Revenue generated through the manufacture, marketing, and distribution of branded, generic, and OTC pharmaceutical products to healthcare providers, pharmacies, and wholesalers.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels1 record

Poly Pharmaceuticals product offering

Product offering

Core offering

Poly Pharmaceuticals is an independent specialty pharmaceutical company that manufactures, markets, and distributes branded, generic, and OTC therapeutic products in tablet and liquid formulations. Its portfolio targets four therapeutic areas — cough and cold, pain management, urological health, and allergy/sinusitis — and is organized into seven core product lines (Alahist, Deconex, Duraflu, Poly Hist, Poly Tussin, Poly Vent, Udamin SP) plus co-promoted Kristalose products. Products are sold to physicians, pharmacies, and wholesalers throughout the United States.

Product overview

Poly Pharmaceuticals is an independent specialty pharmaceutical company that manufactures, markets, and distributes branded, generic, and OTC therapeutic products. The company operates as a single product portfolio rather than a unified platform architecture, organized into multiple product lines targeting cough and cold, pain management, urological health, and allergy and sinusitis conditions. Their product portfolio includes seven core product lines—Alahist, Deconex, Duraflu, Poly Hist, Poly Tussin, Poly Vent, and Udamin SP—along with co-promoted products (Kristalose 10mg and 20mg). Products are distributed in tablet and liquid formulations to physicians, pharmacies, and wholesalers throughout the United States.

Differentiator

Problem solved

Functional benefit

Brands

  • Alahist: Product line including Alahist CF, Alahist IR, Alahist PE, Alahist DM
  • Deconex
  • Duraflu
  • Poly Hist
  • Poly Tussin
  • Poly Vent
  • Udamin SP

Products and services

  • Alahist Product line of cough and cold medications available in tablet form (Alahist CF, Alahist IR, Alahist PE) and liquid form (Alahist DM), distributed to physicians, pharmacies, and wholesalers across the United States.
  • Deconex Product line of decongestant medications available in tablet form (Deconex IR, Deconex DMX), distributed to physicians, pharmacies, and wholesalers in the United States.
  • Duraflu Tablet-form cold medication product line distributed to physicians, pharmacies, and wholesalers in the United States.
  • Poly Hist Product line of antihistamine/cold medications available in multiple formulations (Poly-Hist Forte, Poly-Hist DM, Poly-Hist PD), distributed to physicians, pharmacies, and wholesalers in the United States.
  • Poly Tussin Liquid cough suppressant product line (Polytussin DM) distributed to physicians, pharmacies, and wholesalers in the United States.
  • Poly Vent Product line of respiratory/cold medications available in tablet form (Poly Vent IR, Poly Vent DM), distributed to physicians, pharmacies, and wholesalers in the United States.
  • Udamin SP Urological health product line distributed to physicians, pharmacies, and wholesalers in the United States.
  • Kristalose Co-promoted prescription laxative product available in 10mg and 20mg dosages, distributed to physicians, pharmacies, and wholesalers in the United States.

Companies that use Poly Pharmaceuticals

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Poly Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Poly Pharmaceuticals partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Strategic Business AlliancescoreStrategic or Co-development PartnerPoly Pharmaceuticals brings new products to market each year through strategic business alliances, acquisitions, product development, and licensing arrangements. These partnerships support the company's product portfolio expansion in therapeutic areas including cough/cold, pain management, urological health, and allergy/sinusitis.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Poly Pharmaceuticals competitors and assessment

Company assessment

Broad incumbents

  • ANI Pharmaceuticals: Larger specialty/generic pharma with U.S. manufacturing and broad therapeutic reach including urology — broader portfolio but overlapping channels and customer base with Poly.
  • Lannett Company: Diversified U.S. generic and specialty pharma distributing through wholesalers and pharmacies — same B2B distribution channels and customer types as Poly, though at significantly larger scale.
  • Church & Dwight: Major consumer-health/OTC company with leading brands across cough/cold, allergy, and pain — competes head-on with Poly's core OTC categories despite vastly different scale.
  • Padagis: Specialty generics and OTC pharmaceutical company with strong cough/cold and respiratory franchises (e.g., historically a major player in cough/cold remedies) — directly competes in Poly's core therapeutic categories and share the same pharmacy/wholesaler channels.
  • Haleon: Global consumer-health company owning major OTC brands in cough/cold, allergy, and pain management — competes aggressively in the same shelf categories where Poly's products are dispensed.

Direct peers

  • Almatica Pharma: Specialty pharmaceutical company focused on branded prescription products in CNS, women's health, and urology — comparable scale, sales-led distribution model, and therapeutic categories.
  • Aytu BioPharma: Specialty pharma commercializing prescription and consumer health products with a dedicated sales force in urology, pediatrics, and primary care — similar channel structure and therapeutic-area strategy to Poly.
  • Avion Pharmaceuticals: Independent U.S. specialty pharma focused on women's health, urology, and primary care, distributing through physicians, pharmacies, and wholesalers — directly comparable business model and therapeutic overlap with Poly (notably urology).
  • Vertical Pharmaceuticals (a Trigen Holdings company): Small U.S. specialty pharmaceutical company marketing branded prescription and OTC products through physician and pharmacy channels — closely mirrors Poly's specialty distribution model and therapeutic-area breadth.

Emerging players

  • Founded Pharmaceuticals (Innocutis/Foundrax): Smaller specialty pharma distributing niche branded and prescription products via physician/pharmacy channels with similar lean operating profile to Poly.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat1 record

Key risks6 records

Key highlights5 records

Customer concentration

Poly Pharmaceuticals social profiles

Digital presence

Poly Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Poly Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles1 record

Poly Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Poly Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Poly Pharmaceuticals

What does Poly Pharmaceuticals do?

Poly Pharmaceuticals is an independent specialty pharmaceutical company that manufactures, markets, and distributes branded, generic, and OTC therapeutic products in tablet and liquid formulations. Its portfolio targets four therapeutic areas — cough and cold, pain management, urological health, and allergy/sinusitis — and is organized into seven core product lines (Alahist, Deconex, Duraflu, Poly Hist, Poly Tussin, Poly Vent, Udamin SP) plus co-promoted Kristalose products. Products are sold to physicians, pharmacies, and wholesalers throughout the United States.

Is Poly Pharmaceuticals a public or private company?

Poly Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Poly Pharmaceuticals founded?

Poly Pharmaceuticals was founded in 1980. It employs 11 to 50 people.

Where is Poly Pharmaceuticals based?

Poly Pharmaceuticals is headquartered in Quitman, United States, in the North America region.

How does Poly Pharmaceuticals make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Poly Pharmaceuticals's main competitors?

Broad incumbents on record are ANI Pharmaceuticals, Lannett Company, Church & Dwight, Padagis and Haleon. Direct peers are Almatica Pharma, Aytu BioPharma, Avion Pharmaceuticals and Vertical Pharmaceuticals (a Trigen Holdings company). Founded Pharmaceuticals (Innocutis/Foundrax) is listed as an emerging player.

Does Poly Pharmaceuticals have an API?

No public API is recorded for Poly Pharmaceuticals.

What industry is Poly Pharmaceuticals in?

Poly Pharmaceuticals's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAAAM, Nephrology & Urology Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals